Contineum Therapeutics Files 8-K
Ticker: CTNM · Form: 8-K · Filed: Apr 28, 2025 · CIK: 1855175
| Field | Detail |
|---|---|
| Company | Contineum Therapeutics, Inc. (CTNM) |
| Form Type | 8-K |
| Filed Date | Apr 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, corporate-filing
TL;DR
Contineum Therapeutics filed an 8-K on 4/28/25. Standard disclosure.
AI Summary
Contineum Therapeutics, Inc. filed an 8-K on April 28, 2025, reporting other events and financial statements. The company, formerly known as Pipeline Therapeutics, Inc. until April 5, 2021, is based in San Diego, California.
Why It Matters
This filing indicates Contineum Therapeutics is making official disclosures to the SEC, which could relate to significant corporate events or financial updates.
Risk Assessment
Risk Level: low — This is a routine SEC filing with no immediate indication of negative events.
Key Numbers
- 001-42001 — SEC File Number (Contineum Therapeutics' SEC filing identifier)
- 27-1467257 — IRS Employer Identification No. (Contineum Therapeutics' tax identification number)
Key Players & Entities
- Contineum Therapeutics, Inc. (company) — Registrant
- Pipeline Therapeutics, Inc. (company) — Former company name
- April 28, 2025 (date) — Filing date
- April 5, 2021 (date) — Date of name change
- San Diego, California (location) — Principal executive offices
FAQ
What specific 'Other Events' are being reported in this 8-K filing?
The filing itself does not detail the specific 'Other Events' beyond categorizing them as such. Further review of the document's content would be required.
What is the significance of the company formerly being named Pipeline Therapeutics, Inc.?
The company underwent a name change from Pipeline Therapeutics, Inc. to Contineum Therapeutics, Inc. on April 5, 2021.
Where are Contineum Therapeutics' principal executive offices located?
Contineum Therapeutics' principal executive offices are located at 3565 General Atomics Court, Suite 200, San Diego, California, 92121.
What is the Standard Industrial Classification (SIC) code for Contineum Therapeutics?
The SIC code for Contineum Therapeutics is 2834, which corresponds to Pharmaceutical Preparations.
What is the filing date of this 8-K report?
The 8-K report was filed on April 28, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 28, 2025 regarding Contineum Therapeutics, Inc. (CTNM).